Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

VIB Inks qBase+ Group Licensing Agreement with Biogazelle

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
VIB to accelerate its qPCR analyses by using qbase+ as the software.

BITS, the bio-informatics training and service facility of the Belgian life sciences research institute VIB, has chosen qbase+ as the software to accelerate its qPCR analyses.

The qbase+ group license is available for more than ten VIB departments covering over 1000 researchers.

The director of BITS, Herwig Van Marck, cited: “qbase+ will allow us to improve the accuracy of our results and bring our qPCR based research to a higher level. The peer-reviewed software algorithms will help our researcher to annotate and process qPCR data according to international guidelines. To ensure the quality of the data we can rely on the various calculations available in qbase+ for post-PCR quality control, PCR efficiency correction, normalization, inter-run calibration, and statistics. This way, VIB researchers can efficiently analyze, interpret and visualize their data for various types of analysis: mRNA expression analysis, copy number analysis, miRNA profiling, ChIP-qPCR, and many others.”

While the practical performance of a real-time PCR quantification experiment is relatively straightforward, it is clear that many users experience a genuine need for more in depth training of their data-analysis skills.

To accommodate this need, Biogazelle has organized several training sessions for key qPCR users within VIB.

Within the framework of the collaboration, VIB can also rely on expert advice from Biogazelle.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biogazelle Attracts New Investors
UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth.
Tuesday, October 07, 2014
Biogazelle Serves as Reference Laboratory for Bio-Rad's ddPCR System
Biogazelle’s and Bio-Rad’s long-term partnership extends.
Monday, September 30, 2013
Biogazelle Appoints Kris Vanhercke as Chief Operating Officer
New appointment strengthens business development and marketing expertise of Biogazelle.
Monday, September 24, 2012
Scientific News
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.
Liquid Biopsy for NSCLC
'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Seeing Cell to Cell Differences
Seeing differences between individual cells for first time explains symptoms of rare genetic disorders, finds penn study.
Circular RNAs Implicated in Cancer
Circular RNAs – like their protein counterparts – are also affected by genomic rearrangements in cancer, resulting in abnormal fusions.
Know Thy Helicobacter pylori
Non-invasive method for genotyping H.pylori developed.
Zika Test Authorized for Emergency Use
n response to a request from the CDC, the FDA has issued an Emergency Use Authorization (EUA) for a diagnostic tool for Zika virus that will be distributed to qualified laboratories.
Lighting Up Disease-Carrying Mosquitoes
Sandia’s QUASR enables speedy, accurate detection of West Nile and other viruses.
Ultra-Sensitive Test for Cancers, HIV
Test developed that is thousands of times more sensitive than current diagnostics.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!